FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amedra Pharmaceuticals Dexedrine¿ Recall

Dexedrine¿ (Dextroamphetamine Sulfate) Spansules¿ Sustained Release Capsules 15mg, 90 c…

Amedra Pharmaceuticals LLC · Horsham, PA

Risk level
Class II
Reported by FDA
Jan 1, 2014
Recall ID
D-385-2014
Check your lot numberHow we source this data

Summary

Amedra Pharmaceuticals recalled Dexedrine¿ starting Oct 7, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-385-2014 on Jan 1, 2014. Reason: Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.

Product description

Dexedrine¿ (Dextroamphetamine Sulfate) Spansules¿ Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by Catalent Pharma Solutions Winchester, KY 40391 for Amedra Pharmaceuticals, LLC Middlesex, NJ 08846, NDC 52054-514-09

Lot numbers, UPCs & expiration codes

Lot# 243459; Exp. 01/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-385-2014
Classification
Class II
Status
Terminated
Recall initiated
Oct 7, 2013
FDA report date
Jan 1, 2014
Quantity
10,992 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amedra Pharmaceuticals LLC

Original FDA data

Every field from FDA enforcement report D-385-2014, exactly as published.

Show all FDA fields
City
Horsham
State
PA
Status
Terminated
Country
United States
Event ID
66593
Address
2 Walnut Grove Dr
Address (line 2)
Suite 190
Code information
Lot# 243459; Exp. 01/14
Postal code
19044-2219
Report date
Jan 1, 2014
Product type
Drugs
Recall number
D-385-2014
Classification
Class II
Recalling firm
Amedra Pharmaceuticals LLC
Product quantity
10,992 bottles
Termination date
Oct 7, 2014
Reason for recall
Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dexedrine¿ (Dextroamphetamine Sulfate) Spansules¿ Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by Catalent Pharma Solutions Winchester, KY 40391 for Amedra Pharmaceuticals, LLC Middlesex, NJ 08846, NDC 52054-514-09
Distribution pattern
Nationwide
Recall initiation date
Oct 7, 2013
Initial firm notification
Letter
Center classification date
Dec 23, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-385-2014, published Jan 1, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls